William Padula, PhD, MSc, MS, assistant professor of pharmaceutical and health economics, University of California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, discusses the benefits ...

Jennifer Simonson is a business journalist with a decade of experience covering entrepreneurship and small business. Drawing on her background as a founder of multiple startups, she writes for Forbes ...

As an epidemiologist and physician, I’ve long been concerned about how health interventions for marginalized communities are evaluated. A new study explores that concern and offers some solutions for ...

Multicancer early detection testing results in extended life-years and reduced cancer treatment costs through earlier diagnosis, leading to a cost-effective option in cancer screening. Objectives: ...

Assessing drug cost avoidance in clinical trials: An observational study in a Spanish tertiary hospital. Growth factor use in patients with breast cancer treated with docetaxel, carboplatin, ...

Please provide your email address to receive an email when new articles are posted on . Universal testing for Duffy null phenotype may be cost effective depending on the type of neutropenia workup ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Efanesoctocog alfa prophylaxis is conventionally cost-ineffective compared with standard factor VIII ...

Economic burden of radical cystectomy and trimodal therapy for bladder cancer in the United States: Real-world study. Avelumab first-line maintenance (1LM) in patients (pts) with locally advanced or ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...